Zomedica SG&A Expense (Quarterly) Analysis

Zomedica Corp (ZOM)

0.1632 0.00 (0.00%) USD | NYAM | Jun 03, 16:00

0.1624 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	12.73M
December 31, 2023	13.36M
September 30, 2023	9.443M
June 30, 2023	9.931M
March 31, 2023	10.43M
December 31, 2022	8.654M
September 30, 2022	8.888M
June 30, 2022	8.567M
March 31, 2022	6.703M
December 31, 2021	8.161M
September 30, 2021	6.124M
June 30, 2021	5.038M
March 31, 2021	3.468M
December 31, 2020	3.290M
September 30, 2020	2.298M
June 30, 2020	1.394M
March 31, 2020	1.703M
December 31, 2019	1.864M
September 30, 2019	1.684M
June 30, 2019	1.133M
March 31, 2019	3.971M
December 31, 2018	1.811M

Date	Value
September 30, 2018	1.128M
June 30, 2018	1.585M
March 31, 2018	1.532M
December 31, 2017	1.372M
September 30, 2017	1.597M
June 30, 2017	1.063M
March 31, 2017	1.209M
December 31, 2016	2.37M
September 30, 2016	0.616M
June 30, 2016	0.4785M
February 29, 2016	0.0102M
November 30, 2015	0.0225M
August 31, 2015	0.004M
May 31, 2015	0.0111M
February 28, 2015	0.0111M
November 30, 2014	0.0081M
August 31, 2014	0.0069M
May 31, 2014	0.0079M
February 28, 2014	0.0024M
November 30, 2013	0.0542M
August 31, 2013	0.0069M
May 31, 2013	0.0145M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.133M

Minimum

Jun 2019

13.36M

Maximum

Dec 2023

6.243M

Average

6.414M

Median

SG&A Expense (Quarterly) Benchmarks